StreetAlpha.app
Home › Stocks › SGRY

Surgery Partners, Inc. (SGRY)

Healthcare
$26.85
▲ +0.22%
LAST CLOSE · NOV 17

Surgery Partners operates outpatient surgical facilities and related care services across the United States. It last closed at $26.85 on Nov 17, up 0.22% on the day. The average 12-month price target from 5 analysts is $27.70 (+3.2% from the last close), with a high of $50.00 and a low of $15.00. Analyst consensus is Hold, based on the latest ratings from 5 firms (1 buy, 4 hold, 0 sell). In the past 30 days there were 10 dark pool prints totaling $26.0M, the largest $11.6M.

AI Auto Pilots
Is SGRY in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$3.4B
+2.2% vs a year ago
Net income
−$87.0M
−2.6% margin
EPS (diluted)
−$0.67
Free cash flow
$202.8M
6.0% margin
Valuation
Market cap
$3.5B
130.9M shares
P/E
–
No P/E while losing money
Price to sales
1.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$354.5M
At Sep 30
Shareholder equity
$1.7B
Shares outstanding
130.9M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $2.2B$2.2BFY2021FY2022: $2.5B$2.5BFY2022FY2023: $2.7B$2.7BFY2023FY2024: $3.1B$3.1BFY2024FY2025: $3.3B$3.3BFY2025

From SGRY's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Last report
Nov 9
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Hold
Based on 5 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
5firms
1 Buy4 Hold0 Sell
Each firm's latest rating on SGRY in the past 90 days
Average 12-month target
$27.70
▲ 3.2% upside

Based on 5 analysts who set a price target on SGRY in the past 90 days. The average target is $27.70, with a high of $50.00 and a low of $15.00, compared with the last close of $26.85.

Low $15.00Avg $27.70High $50.00
Blue marker: last close $26.85
Highest target$50.00
Average target$27.70
Lowest target$15.00
Latest rating changes
TD CowenTarget raised
Nov 11Hold$19 → $25
RBC CapitalTarget raised
Nov 10Hold$19 → $25
UBSDowngrade
Oct 28Hold$23.50
RBC CapitalReiterated
Sep 30Buy$19
BenchmarkReiterated
Sep 25Buy$50
DateFirmActionRatingPrice target
Nov 11TD CowenTarget raisedHold$19 → $25
Nov 10RBC CapitalTarget raisedHold$19 → $25
Oct 28UBSDowngradeHold$23.50
Sep 30RBC CapitalReiteratedBuy$19
Sep 25BenchmarkReiteratedBuy$50
Loading…

Technical Analysis

SGRY · as of the Nov 17 close · updated after every close
Uptrend, overbought

The stock is 13% above its 20 day and 34% above its 50 day average. It is 43% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 88), overbought. The nearest support is the Pivot at $26.80, and the nearest resistance the Pivot R1 at $26.93.

Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityLow, 2.5%/day
Key levels
$27.2352 week high+1.4%
$27.23Swing high (Nov 9)+1.4%
$26.93Pivot R1+0.3%
$26.85Last close
$26.80Pivot−0.2%
$26.72Pivot S1−0.5%
$23.3120 day average−13.2%
$23.12Swing low (Nov 2)−13.9%
$17.8150 day average−33.7%
$16.57100 day average−38.3%
$15.21200 day average−43.4%
$11.4152 week low−57.5%
Indicators
RSI (14)87.94Overbought above 70Overbought
MACD2.82Above its signal lineBullish
Stochastic91.1Near the top of its rangeOverbought
ADX (14)68.4Strong uptrend
Williams %R-9.1Oversold below −80, overbought above −20Overbought
CCI (20)98.7Oversold below −100, overbought above 100Neutral
Rate of change+16.1%Change over 10 sessionsBullish
ATR (14)$0.67Typical daily range, 2.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for SGRY

What happened before

See how SGRY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow SGRY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How SGRY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in SGRY in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
10
Notional
$26.0M
Largest print
$11.6M
Loading…

SGRY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲106 buying vs 86 selling
  • ▼Held by funds -5.4 pts
  • ▲Funds holding +2
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding191189+1.1%
In funds' top 1035−40.0%
Held by funds115.2%120.6%−5.4 pts
New / increased36 / 7035 / 72−0.9%
Reduced / sold out54 / 3251 / 27+10.3%
Put/call ratio1.150.11+927.1%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SGRY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SGRY is in one of them and how their past SGRY trades turned out.

SGRY in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SGRY in an article yet. Here's the latest on the wider market.

About Surgery Partners

Surgery Partners operates a national network of surgical facilities across the United States. Its facilities include outpatient surgery centers, surgical hospitals, anesthesia services, urgent care clinics and physician practices, with most focused on planned procedures that do not require a hospital stay. Its patients are mainly covered by private insurance and government programs such as Medicare. The company is based in Brentwood, Tennessee.

Headquarters
Brentwood, TN